Xcellerate
Commercial- Indications
- Wound healing, Surgical applications
Company intelligence / Profile preview
Precise Bioscience
North Sioux City, South Dakota, United Statesprecisebioscience.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Precise Bioscience developed advanced lyophilized amniotic membrane products designed for flexibility and ease of use, featuring a proprietary process that preserves the extracellular matrix and growth factors
- Therapeutic areas
- OtherDermatologyInfectious Diseases
- Modalities
- Lyophilized amniotic membrane technology
- Industry
- Consumable Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Precise Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Precise Bioscience.